Dec 10
|
3 Unstoppable Stocks to Buy Right Now
|
Dec 8
|
Eli Lilly (LLY) Rises Higher Than Market: Key Facts
|
Dec 8
|
Lilly Announces 15% Dividend Increase, First-Quarter 2024 Dividend
|
Dec 8
|
Pharma Stock Roundup: ABBV to Buy CERE, JNJ's 2024 View, LLY & NVS Get FDA Nod
|
Dec 8
|
Positive News Drove Eli Lilly and Company (LLY) in Q3
|
Dec 8
|
Could Eli Lilly Beat Novo Nordisk in the Billion-Dollar Weight Loss Market?
|
Dec 8
|
Zacks Market Edge Highlights: SAIC, ANET, LLY, PFE and SIG
|
Dec 7
|
Chase Coleman Stock Portfolio: 10 Top Stock Picks
|
Dec 7
|
Will There Be a Recession in 2024?
|
Dec 7
|
Top 20 Most Valuable American Companies Today
|
Dec 7
|
Dow Jones Climbs After Jobless Claims Rise; Google Stock Surges After Gemini AI Model
|
Dec 7
|
13 Best S&P 500 Dividend Stocks To Buy
|
Dec 7
|
Should You Buy Eli Lilly Stock Now or Wait for a Dip?
|
Dec 7
|
Which Stock Is More Likely to Help You Retire as a Millionaire: AbbVie or Eli Lilly?
|
Dec 6
|
5 Things to Know Before Markets Open
|
Dec 5
|
Pfizer’s Weight-Loss Pill Disappointment Is an Opening for Biotech Rivals
|
Dec 5
|
13 Best Jim Cramer Stocks To Buy Now
|
Dec 5
|
Lilly to Present Final Overall Survival Analysis from the MONARCH 3 Study of Verzenio® (abemaciclib) and Additional Results from Its Breast Cancer Portfolio at the 2023 San Antonio Breast Cancer Symposium
|
Dec 5
|
Eli Lilly obesity drug now available in US pharmacies
|
Dec 5
|
UPDATE 4-Eli Lilly obesity drug now available in US pharmacies
|